Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder

GlobeNewswire Inc. | Sep 24, 2026 7:00 AM EDT

Exploratory research results presented at Psych Congress 2026 in New Orleans